| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/23/2009 | WO2004028479A9 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/23/2009 | US20090105149 Compounds comprising lpa |
| 04/23/2009 | US20090105137 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 04/23/2009 | US20090104684 Diagnosis of carcinomas |
| 04/23/2009 | US20090104220 Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity |
| 04/23/2009 | US20090104210 Peptide compounds for treating obesity and insulin resistance |
| 04/23/2009 | US20090104180 Using selectin/immunoglobulin fusion for quelling organ transplant rejection |
| 04/23/2009 | US20090104178 Chemokine binding activity of viral tnf receptors and related proteins |
| 04/23/2009 | US20090104150 Polymer conjugates of interferon Beta-1a and uses |
| 04/23/2009 | CA2702686A1 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 04/23/2009 | CA2701329A1 Combination of blys inhibition and anti-cd 20 agents for treatment of autoimmune disease |
| 04/22/2009 | EP2050818A1 Transcriptional activators with graded transactivation potential |
| 04/22/2009 | EP2050762A2 Novel polypeptides and nucleic acids encoding the same |
| 04/22/2009 | EP2049565A1 Positive cytomodulines to improve bioreactor productivity. |
| 04/22/2009 | EP1951319A4 Chimeric immunoreceptor useful in treating human cancers |
| 04/22/2009 | EP1651664B1 Ligation method |
| 04/22/2009 | EP1468014B1 Compositions and methods for WT1 specific immunotherapy |
| 04/22/2009 | EP1395648B1 Methods for binding acma-type protein anchor fusions to cell-wall material of micro-organisms |
| 04/22/2009 | EP1090039B1 Peptide composition as immunogen for the treatment of allergy |
| 04/22/2009 | CN101413009A Preparation of human amylin mutant-pramlintide with modified structure |
| 04/22/2009 | CN101413002A Recombinant Kluyveromyces sp. expressing antibody or antibody analogue, and construction method and use thereof |
| 04/22/2009 | CN100480272C Iluman wild type P53 fusion protein |
| 04/22/2009 | CN100480271C Recombinant pronucleus expressed and detected antigen for VII genetype newcastle disease virus NP antibody and preparation method thereof |
| 04/22/2009 | CN100480266C Interferon-beta fusion proteins and uses |
| 04/21/2009 | US7521532 Comprises nucleotide sequences coding transmembrane protein for diagnosis and treatment immunological and autoimmune diseases |
| 04/21/2009 | US7521422 Use of aspartic proteases in cosmetics and therapeutics |
| 04/21/2009 | US7521240 Chromosome-based platforms |
| 04/21/2009 | CA2193641C 66 kda antigen from borrelia |
| 04/21/2009 | CA2115927C Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 04/16/2009 | WO2009048133A1 Mite antigenic rice |
| 04/16/2009 | WO2009046541A1 MODULATION OF SIRPα - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR |
| 04/16/2009 | WO2009046520A1 A fusion tag comprising an affinity tag and an ef-hand motif containing polypeptide and methods of use thereof |
| 04/16/2009 | WO2008039483A9 Modified self-assembling peptides |
| 04/16/2009 | US20090100535 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098579 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners; modulating taste perception |
| 04/16/2009 | US20090098544 Marker molecules associated with lung tumors |
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098148 High efficiency tissue-specific compound delivery system using streptavadin-protein a fusion protein |
| 04/16/2009 | US20090098147 Antibody fragment-polymer conjugates and uses of same |
| 04/16/2009 | US20090098130 Glucagon-like protein-1 receptor (glp-1r) agonist compounds |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | CA2702400A1 Mite antigenic rice |
| 04/16/2009 | CA2702217A1 Modulation of sirp.alpha. - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 04/16/2009 | CA2701369A1 Modified growth hormone polypeptides |
| 04/15/2009 | EP2046831A2 Novel multivalent immunoglobulins |
| 04/15/2009 | EP2046826A2 Exendin fusion proteins |
| 04/15/2009 | EP2046812A1 A cancer vaccine comprising a mucin 1 (muc1) t cell epitope-derived peptide |
| 04/15/2009 | CN101407541A Modified allosteric type cyclic citrulline polypeptide, and fusion protein, antibody and reagent kit thereof |
| 04/15/2009 | CN100478439C Prawn antiviral growth-promoting double-function engineering strain, construct method and application |
| 04/14/2009 | US7517526 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents |
| 04/14/2009 | CA2130900C Therapeutic domains of von willebrand factor |
| 04/09/2009 | WO2009045062A1 Cell permeable fusion protein for facilitating ossification and use thereof |
| 04/09/2009 | WO2009043277A1 Skin care composition containing hsa fusion protein, method for preparation and use thereof |
| 04/09/2009 | WO2006073446A3 Peptide-mediated protein transduction into cells the hematopoietic lineage |
| 04/09/2009 | WO2005032496A3 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/09/2009 | US20090093619 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 04/09/2009 | US20090093402 Albumin Fusion Proteins |
| 04/09/2009 | US20090093051 T1R1 Nucleic Acid Sequences and Vectors Containing Same |
| 04/09/2009 | US20090093025 Twin-arginine translocation in Bacillus |
| 04/09/2009 | US20090092664 Polymer-metal chelator conjugates and uses thereof |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092601 HUMANIZED ANTI-LT-beta-R ANTIBODIES |
| 04/09/2009 | US20090092597 Mammalian cell surface antigens; related reagents |
| 04/08/2009 | EP2045269A1 Novel chimeric analgesic peptides |
| 04/08/2009 | EP2045265A1 GLP-1 fusion peptides, their production and use |
| 04/08/2009 | EP2044125A1 Compositions and methods for delivering anti-activated ras antibodies into cells |
| 04/08/2009 | EP1244692B1 Compositions and methods for detecting stress-inducible proteins |
| 04/08/2009 | EP1007569B1 Stimulation of an immune response with antibodies labeled with the alpha-galactosyl epitope |
| 04/08/2009 | CN101405393A The use of protein S fusion for protein solubilization |
| 04/08/2009 | CN101405300A Methods and compositions for antagonism of RAGE |
| 04/08/2009 | CN101402688A Fusion protein, encoding gene and uses thereof |
| 04/08/2009 | CN101402687A Fusion protein with high immunogenicity and uses thereof |
| 04/08/2009 | CN100475849C Tetravalence single chain antibody of p53 tetra polymerized structure domain |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475836C Mesenchymal stem cell affinity peptide screening and use |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514535 Chimeric immunogens |
| 04/07/2009 | US7514398 Growth factor complex |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2313704C Recombinant nodavirus compositions and methods |
| 04/07/2009 | CA2311643C Compositions and methods for inducing gene expression |
| 04/07/2009 | CA2269060C Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/07/2009 | CA2220447C Novel fusion protein recovery and purification methods |
| 04/02/2009 | WO2009042162A2 Compositions and methods for inhibiting interleukin pathways |
| 04/02/2009 | WO2009039630A1 Optimized nucleic acid sequences for the expression of vb4-845 |
| 04/02/2009 | WO2009014404A3 Multifunctional protein simultaneously delivering antibodies and nanoparticles |
| 04/02/2009 | WO2008054881A3 Antibacterial and plasmid elimination agents |
| 04/02/2009 | US20090088559 Method for preparing modified polypeptides |
| 04/02/2009 | US20090088390 Polypeptide |
| 04/02/2009 | US20090087458 Activatable recombinant neurotoxins |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/02/2009 | US20090087423 Novel protein complex and use thereof |
| 04/02/2009 | CA2700815A1 Optimized nucleic acid sequences for the expression of vb4-845 |
| 04/02/2009 | CA2700170A1 Genomic editing in zebrafish using zinc finger nucleases |
| 04/02/2009 | CA2700162A1 Cell-permeabilising peptides and polypeptides for microbial cells |
| 04/01/2009 | EP2042598A1 5T4 tumour-associated antigen for use in tumour immunotherapy |